AI BIO DUE DILIGENCE
BIOTECHNOLOGY INVESTORS AND FINANCIAL EXECUTIVES
About AI BIO
AI and machine learning in biotechnology has the power to filter and extract value from volumes of raw digital information housed in the world’s largest data banks. These technologies can sort through millions of data points in seconds and deliver complete data coverage far beyond that which individual scientific consultants regardless of title or position, can ever do. Further, when coupled with any one of dozens of modern “docking software” programs this process can be extremely predictive of the success or failure of an initial hypothesis or target interaction.
Our Services
Technical Due Diligence Reports
AI BIO’s due diligence services protect clients from unforeseen problems by using a combination of open-source machine learning algorithms, public, proprietary and research databases with docking software to help our clients chose from competing alternative investments in early-stage biotechnology startups.
Investigational Due Diligence Services
AI BIO finds that in many cases a due diligence investigation requires a consultative approach. Even in the transparent, seemingly well-published academic plateaus of the world, misrepresentation of information in a “publish or perish” environment is not a rare event.
Strategic Advisory Consultancy
Clients trust AI BIO to steer them thru the complex technical evaluations of their hypothesis using machine learning algorithms that are designed for protein-on-protein interactions in the context of regulatory and scientific factors that impact their professional reputations and/or their operations.
Risk Intelligence Reviews
Competition in today’s deal flow market for breakthrough biotech products is largely commoditized, with little differentiation. Whether faced with the consultant’s favorite technology of the day with sky high valuations in a transparent market or with a lack of reliable information in a more opaque environment, AI BIO positions its clients for success with a decisive information advantage.
Grant Proposal Support
AI BIO staff have successfully raised millions of dollars in non-dilutive funding through federal and university grant programs. We can provide impressive principal investigators for clients and support them with compelling technical reports along with best practices in securing grant funding for translating technologies into products. Founders who can include a report of an AI analysis of the technology indicating its potential success will be more likely to be granted funding.
CMC Consulting
Our scientists and subject matter experts are committed to helping organizations like yours develop new and better drug formulations using AI machine learning and help you navigate development in the digital age.